Marketing status of Fluosol.
D002170:Canada; D004338:Drug Combinations; D005466:Fluorocarbons; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives; D007883:Legislation, Medical
D004338:Drug Combinations; D005466:Fluorocarbons; D006895:Hydroxyethyl Starch Derivatives; C017323:glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination